136 related articles for article (PubMed ID: 21159499)
21. Small airways ventilation heterogeneity and hyperinflation in COPD: response to tiotropium bromide.
Verbanck S; Schuermans D; Vincken W
Int J Chron Obstruct Pulmon Dis; 2007; 2(4):625-34. PubMed ID: 18268937
[TBL] [Abstract][Full Text] [Related]
22. Effects of bronchodilators on dynamic hyperinflation following hyperventilation in patients with COPD.
Fujimoto K; Yoshiike F; Yasuo M; Kitaguchi Y; Urushihata K; Kubo K; Honda T
Respirology; 2007 Jan; 12(1):93-9. PubMed ID: 17207032
[TBL] [Abstract][Full Text] [Related]
23. Paradoxical trough effects of triple therapy with budesonide/formoterol and tiotropium bromide on pulmonary function outcomes in COPD.
Williamson PA; Short PM; Clearie KL; Vaidyanathan S; Fardon TC; Howaniec LJ; Lipworth BJ
Chest; 2010 Sep; 138(3):595-604. PubMed ID: 20418370
[TBL] [Abstract][Full Text] [Related]
24. Bronchodilator efficacy of tiotropium-formoterol via single pressurized meter dose inhaler (pMDI) versus tiotropium alone in COPD.
Salvi S; Brashier B; Gothi D; Karkhanis V; Madas S; Gogtay J; Joshi J
Pulm Pharmacol Ther; 2014 Feb; 27(1):90-5. PubMed ID: 23752057
[TBL] [Abstract][Full Text] [Related]
25. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.
Diba C; King GG; Berend N; Salome CM
Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091
[TBL] [Abstract][Full Text] [Related]
26. Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.
Decramer M; Celli B; Kesten S; Lystig T; Mehra S; Tashkin DP;
Lancet; 2009 Oct; 374(9696):1171-8. PubMed ID: 19716598
[TBL] [Abstract][Full Text] [Related]
27. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium.
Donohue JF; Fogarty C; Lötvall J; Mahler DA; Worth H; Yorgancioglu A; Iqbal A; Swales J; Owen R; Higgins M; Kramer B;
Am J Respir Crit Care Med; 2010 Jul; 182(2):155-62. PubMed ID: 20463178
[TBL] [Abstract][Full Text] [Related]
28. Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study.
Bateman ED; van Dyk M; Sagriotis A
Pulm Pharmacol Ther; 2008; 21(1):20-5. PubMed ID: 17118684
[TBL] [Abstract][Full Text] [Related]
29. Simplified detection of dynamic hyperinflation.
Gelb AF; Gutierrez CA; Weisman IM; Newsom R; Taylor CF; Zamel N
Chest; 2004 Dec; 126(6):1855-60. PubMed ID: 15596684
[TBL] [Abstract][Full Text] [Related]
30. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
[TBL] [Abstract][Full Text] [Related]
31. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.
Casaburi R; Kukafka D; Cooper CB; Witek TJ; Kesten S
Chest; 2005 Mar; 127(3):809-17. PubMed ID: 15764761
[TBL] [Abstract][Full Text] [Related]
32. Computed tomography assessment of pharmacological lung volume reduction induced by bronchodilators in COPD.
Tanabe N; Muro S; Oguma T; Sato S; Kiyokawa H; Takahashi T; Kudo M; Kinose D; Kubo T; Hoshino Y; Ogawa E; Hirai T; Mishima M
COPD; 2012 Aug; 9(4):401-8. PubMed ID: 22509949
[TBL] [Abstract][Full Text] [Related]
33. Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease.
Casaburi R; Maltais F; Porszasz J; Albers F; Deng Q; Iqbal A; Paden HA; O'Donnell DE;
Ann Am Thorac Soc; 2014 Nov; 11(9):1351-61. PubMed ID: 25289942
[TBL] [Abstract][Full Text] [Related]
34. Preoperative use of inhaled tiotropium in lung cancer patients with untreated COPD.
Kobayashi S; Suzuki S; Niikawa H; Sugawara T; Yanai M
Respirology; 2009 Jul; 14(5):675-9. PubMed ID: 19476597
[TBL] [Abstract][Full Text] [Related]
35. Acute bronchodilator responsiveness to tiotropium in postinfectious bronchiolitis obliterans in children.
Teixeira MFC; Rodrigues JC; Leone C; Adde FV
Chest; 2013 Sep; 144(3):974-980. PubMed ID: 23558666
[TBL] [Abstract][Full Text] [Related]
36. Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: the BRIGHT study.
Beeh KM; Korn S; Beier J; Jadayel D; Henley M; D'Andrea P; Banerji D
Respir Med; 2014 Apr; 108(4):584-92. PubMed ID: 24534204
[TBL] [Abstract][Full Text] [Related]
37. Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparison.
Mahler DA; D'Urzo A; Bateman ED; Ozkan SA; White T; Peckitt C; Lassen C; Kramer B;
Thorax; 2012 Sep; 67(9):781-8. PubMed ID: 22544891
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].
Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N;
Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228
[TBL] [Abstract][Full Text] [Related]
39. Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study.
Vogelmeier C; Kardos P; Harari S; Gans SJ; Stenglein S; Thirlwell J
Respir Med; 2008 Nov; 102(11):1511-20. PubMed ID: 18804362
[TBL] [Abstract][Full Text] [Related]
40. Comparison of airway dimensions with once daily tiotropium plus indacaterol versus twice daily Advair(®) in chronic obstructive pulmonary disease.
Hoshino M; Ohtawa J; Akitsu K
Pulm Pharmacol Ther; 2015 Feb; 30():128-33. PubMed ID: 25183687
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]